{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T11:56:36Z","timestamp":1775303796589,"version":"3.50.1"},"reference-count":39,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2004,3,1]],"date-time":"2004-03-01T00:00:00Z","timestamp":1078099200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2004,3,1]],"date-time":"2004-03-01T00:00:00Z","timestamp":1078099200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,8]],"date-time":"2022-06-08T00:00:00Z","timestamp":1654646400000},"content-version":"vor","delay-in-days":6673,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","exphem.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Hematology"],"published-print":{"date-parts":[[2004,3]]},"DOI":"10.1016\/j.exphem.2003.12.001","type":"journal-article","created":{"date-parts":[[2004,3,2]],"date-time":"2004-03-02T14:36:36Z","timestamp":1078238196000},"page":"254-260","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Determination of chromosome 13 status in bone marrow cells of patients with multiple myeloma using combined morphologic and fluorescence in situ hybridization analysis"],"prefix":"10.1016","volume":"32","author":[{"given":"Izhar","family":"Hardan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachel","family":"Rothman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alain","family":"Gelibter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ninette","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Avichai","family":"Shimoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maya","family":"Sokolovsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Malka","family":"Reichart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Galina","family":"Ishoev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ninette","family":"Amariglio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gideon","family":"Rechavi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arnon","family":"Nagler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luba","family":"Trakhtenbrot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.exphem.2003.12.001_BIB1","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1056\/NEJM199402173300709","article-title":"The treatment of multiple myeloma","volume":"330","author":"Alexanian","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/j.exphem.2003.12.001_BIB2","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1056\/NEJM199607113350204","article-title":"A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma","volume":"335","author":"Attal","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.exphem.2003.12.001_BIB3","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1056\/NEJM199911183412102","article-title":"Antitumor activity of thalidomide in refractory multiple myeloma","volume":"21","author":"Singhal","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.exphem.2003.12.001_BIB4","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1046\/j.1365-2141.2001.02726.x","article-title":"Progress in allogenic bone marrow and peripheral blood stem cell transplantation for multiple myeloma: a comparison between transplants performed 1983\u201393 and 1994\u20138 at European Group for Blood and Marrow Transplantation centres","volume":"113","author":"Gahrton","year":"2001","journal-title":"Br J Haematol"},{"key":"10.1016\/j.exphem.2003.12.001_BIB5","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1182\/blood.V97.3.631","article-title":"Melphalan and purine analog containing preparative regimens: reduced-intensity conditioning for patients with hematologic malignancies undergoing allogeneic progenitor cell transplantation","volume":"97","author":"Giralt","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2003.12.001_BIB6","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1200\/JCO.2002.20.5.1295","article-title":"Improved outcome of allogeneic transplantation in high-risk multiple myeloma patients after nonmyeloablative conditioning","volume":"20","author":"Badros","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.exphem.2003.12.001_BIB7","first-page":"S72","article-title":"Stem cell transplantation from related and unrelated donors in multiple myeloma after a reduced intensity fludarabine\/melphalan conditioning. Multiple Myeloma 9th International Workshop","volume":"4","author":"Kroger","year":"2003","journal-title":"Hematol Journal"},{"key":"10.1016\/j.exphem.2003.12.001_BIB8","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1182\/blood-2002-03-0996","article-title":"Immunomodulatory drug CC-5013 overcomes drug resistance and is well tolerated in patients with relapsed multiple myeloma","volume":"100","author":"Richardson","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2003.12.001_BIB9","first-page":"S76","article-title":"The role of arsenic trioxide in multiple myeloma. Multiple Myeloma 9th International Workshop","volume":"4","author":"Hussein","year":"2003","journal-title":"Hematol J"},{"key":"10.1016\/j.exphem.2003.12.001_BIB10","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1002\/1097-0142(197509)36:3<842::AID-CNCR2820360303>3.0.CO;2-U","article-title":"A clinical staging system for multiple myeloma: correlation of measured myeloma cell mass with presenting clinical features, response to treatment and survival","volume":"36","author":"Durie","year":"1975","journal-title":"Cancer"},{"key":"10.1016\/j.exphem.2003.12.001_BIB11","first-page":"S42","article-title":"Development of an International prognostic index (IPI) for myeloma: report of the International Myeloma Working Group. Multiple Myeloma 9th International Workshop","volume":"4","author":"Greipp","year":"2003","journal-title":"Hematol J"},{"key":"10.1016\/j.exphem.2003.12.001_BIB12","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1146\/annurev.genet.32.1.495","article-title":"The critical role of chromosome translocations in human leukemias","volume":"32","author":"Rowley","year":"1998","journal-title":"Annu Rev Genet"},{"key":"10.1016\/j.exphem.2003.12.001_BIB13","doi-asserted-by":"crossref","first-page":"2659","DOI":"10.1200\/JCO.1997.15.7.2659","article-title":"Unique role of cytogenetics in the prognosis of patients with myeloma receiving high-dose therapy and autotransplants","volume":"15","author":"Tricot","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.exphem.2003.12.001_BIB14","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1046\/j.1365-2141.1998.00657.x","article-title":"Prognostic value of cytogenetics in multiple myeloma","volume":"101","author":"Seong","year":"1998","journal-title":"Br J Haematol"},{"key":"10.1016\/j.exphem.2003.12.001_BIB15","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1182\/blood-2002-03-0749","article-title":"Recurrent 14q32 translocations determine the prognosis of multiple myeloma, especially in patients receiving intensive chemotherapy","volume":"100","author":"Moreau","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2003.12.001_BIB16","first-page":"S24","article-title":"Molecular cytogenetics of myeloma biology: clinical and prognostic implications. Multiple Myeloma 9th International Workshop","volume":"4","author":"Fonseca","year":"2003","journal-title":"Hematol J"},{"key":"10.1016\/j.exphem.2003.12.001_BIB17","doi-asserted-by":"crossref","first-page":"3366","DOI":"10.1182\/blood.V91.9.3366","article-title":"Prognostic value of numerical chromosome aberrations in multiple myeloma: a FISH analysis of 15 different chromosomes","volume":"91","author":"Perez-Simon","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2003.12.001_BIB18","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1200\/JCO.2000.18.4.804","article-title":"Predictive role of interphase cytogenetics for survival of patients with multiple myeloma","volume":"18","author":"Konigsberg","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.exphem.2003.12.001_BIB19","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1182\/blood.V95.6.1925","article-title":"Deletion of 13q14 remains an independent adverse prognostic variable in multiple myeloma despite its frequent detection by interphase fluorescence in situ hybridization","volume":"95","author":"Zojer","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2003.12.001_BIB20","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1182\/blood.V97.6.1566","article-title":"Chromosome 13 abnormalities identified by FISH analysis and serum beta2\u2013microglobulin produce a powerful myeloma staging system for patients receiving high-dose therapy","volume":"97","author":"Facon","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2003.12.001_BIB21","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1182\/blood.V97.3.822","volume":"97","author":"Avet-Loiseau","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2003.12.001_BIB22","first-page":"715","article-title":"Biological and prognostic significance of interphase fluorescence in situ hybridization detection of chromosome 13 abnormalities (\u039413) in multiple myeloma","volume":"62","author":"Fonseca","year":"2002","journal-title":"Cancer Res"},{"key":"10.1016\/j.exphem.2003.12.001_BIB23","first-page":"276","article-title":"The biology and cytogenetics of multiple myeloma","volume":"6","author":"Ho","year":"2002","journal-title":"Exp Hematol"},{"key":"10.1016\/j.exphem.2003.12.001_BIB24","first-page":"S44","article-title":"The major prognostic value of cytogenetics in myeloma. Multiple Myeloma 9th International Workshop","volume":"4","author":"Tricot","year":"2003","journal-title":"Hematol J"},{"key":"10.1016\/j.exphem.2003.12.001_BIB25","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1182\/blood.V99.6.2185","article-title":"Intergroupe Francophone du Myelome. Oncogenesis of multiple myeloma: 14q32 and 13q chromosomal abnormalities are not randomly distributed, but correlate with natural history, immunological features, and clinical presentation","volume":"99","author":"Avet-Loiseau","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2003.12.001_BIB26","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1046\/j.1365-2141.2003.04172.x","article-title":"Cytogenetics of multiple myeloma: interpretation of fluorescence in situ hybridization results","volume":"120","author":"Harrison","year":"2003","journal-title":"Br J Haematol"},{"key":"10.1016\/j.exphem.2003.12.001_BIB27","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1038\/sj.leu.2402581","article-title":"Chimerism testing and detection of minimal residual disease after allogeneic hematopoietic transplantation using the BioView (Duet) combined morphological and cytogenetical analysis","volume":"16","author":"Shimoni","year":"2002","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2003.12.001_BIB28","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1038\/sj.leu.2402604","article-title":"Chimerism testing and detection of minimal residual disease after allogeneic hematopoietic transplantation using the Duet\u2122 (BioView) combined morphological and cytogenetical analysis","volume":"16","author":"Trakhtenbrot","year":"2002","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2003.12.001_BIB29","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1155\/1998\/764986","article-title":"Fast-FISH detection and semi-automated image analysis of numerical chromosome aberrations in hematological malignancies","volume":"16","author":"Esa","year":"1998","journal-title":"Anal Cell Pathol"},{"key":"10.1016\/j.exphem.2003.12.001_BIB30","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/S0165-4608(00)00315-0","article-title":"Standardization criteria for the detection of BCR\/ABL fusion in interphase nuclei of chronic myelogenous leukemia patients by fluorescence in situ hybridization","volume":"123","author":"Cohen","year":"2000","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.exphem.2003.12.001_BIB31","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1046\/j.1365-2141.2000.02248.x","article-title":"Multiple myeloma with deletion of chromosome 13q is characterized by increased bone marrow I","volume":"110","author":"Schreiber","year":"2000","journal-title":"Br J Haematol"},{"key":"10.1016\/j.exphem.2003.12.001_BIB32","first-page":"728a","article-title":"Deletion of chromosome 13q14 detected by fluorescence in situ hybridization as prognostic factor following allogeneic dose-reduced stem cell transplantation in patients with multiple myeloma. 45th ASH Annual Meeting","volume":"102","author":"Kroger","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2003.12.001_BIB33","first-page":"3854","article-title":"Multiple myeloma: high incidence of chromosomal aneuploidy as detected by interphase fluorescence in situ hybridization","volume":"55","author":"Drach","year":"1995","journal-title":"Cancer Res"},{"key":"10.1016\/j.exphem.2003.12.001_BIB34","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0165-4608(97)00408-1","article-title":"Detection of RB1 deletions by fluorescence in situ hybridization in malignant hematologic disorders","volume":"103","author":"Juneau","year":"1998","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.exphem.2003.12.001_BIB35","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1046\/j.1365-2141.2003.03948.x","article-title":"Prognostic impact of cytogenetic and interphase fluorescence in situ hybridization- defined chromosome 13 deletion in multiple myeloma: early results of total therapy II","volume":"120","author":"Shaughnessy","year":"2003","journal-title":"Br J Haematol"},{"key":"10.1016\/j.exphem.2003.12.001_BIB36","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1007\/s002770100366","article-title":"New insights into the biology of multiple myeloma using a combination of May-Grunwald-Giemsa staining and fluorescence in situ hybridization techniques at the single cell level","volume":"80","author":"Nickenig","year":"2001","journal-title":"Ann Hematol"},{"key":"10.1016\/j.exphem.2003.12.001_BIB37","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0002-9440(10)65245-5","article-title":"Combined morphological and interphase fluorescence in situ hybridization study in multiple myeloma of Chinese patients","volume":"154","author":"Ng","year":"1999","journal-title":"Am J Pathol"},{"key":"10.1016\/j.exphem.2003.12.001_BIB38","first-page":"392a","article-title":"Detection of 13q Deletion in the bone marrow cells of patients with multiple myeloma using combined morphological and FISH analysis. 44th ASH Annual Meeting","volume":"100","author":"Hardan","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2003.12.001_BIB39","doi-asserted-by":"crossref","first-page":"3919","DOI":"10.1182\/blood-2002-04-1150","article-title":"Unrelated stem cell transplantation in multiple myeloma after a reduced- intensity conditioning with pretransplantation antithymocyte globulin is highly effective with low transplantation-related mortality","volume":"100","author":"Kroger","year":"2002","journal-title":"Blood"}],"container-title":["Experimental Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X03004132?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X03004132?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T08:18:16Z","timestamp":1759565896000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301472X03004132"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,3]]},"references-count":39,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2004,3]]}},"alternative-id":["S0301472X03004132"],"URL":"https:\/\/doi.org\/10.1016\/j.exphem.2003.12.001","relation":{},"ISSN":["0301-472X"],"issn-type":[{"value":"0301-472X","type":"print"}],"subject":[],"published":{"date-parts":[[2004,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Determination of chromosome 13 status in bone marrow cells of patients with multiple myeloma using combined morphologic and fluorescence in situ hybridization analysis","name":"articletitle","label":"Article Title"},{"value":"Experimental Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exphem.2003.12.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2004 International Society for Experimental Hematology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}